• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡基因效应与常染色体显性遗传性耳聋15型的临床异质性相关。

Oligogenic effect is associated with the clinical heterogeneity of autosomal dominant deafness-15.

作者信息

Pan Jianyan, Teng Hua, Liu Fang, Chen Siyi, Liu Yaning, Teng Yanling, Liang Desheng, Li Zhuo, Wu Lingqian

机构信息

Center for Medical Genetics, Hunan Key Laboratory of Medical Genetics, MOE Key Lab of Rare Pediatric Diseases, School of Life Sciences, Central South University, Changsha, 410000, Hunan, China.

Department of Birth Health and Genetics, The Reproductive Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530000, Guangxi, China.

出版信息

Sci Rep. 2025 Jan 15;15(1):1981. doi: 10.1038/s41598-025-85881-8.

DOI:10.1038/s41598-025-85881-8
PMID:39809934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11733205/
Abstract

Autosomal dominant deafness-15 which is caused by mutation in the POU4F3 gene, has been reported with a wide degree of clinical heterogeneity, even between intrafamilial members. However, the reason is still elusive. In this study, A four-generation Chinese family with 11 patients manifesting late-onset progressive non-syndromic hearing loss was recruited. The phenotype of hearing loss in this family showed a large variability in terms of onset age and progression speed. A novel mutation (c.706 C > T, p.L236F) was identified by the whole exome sequencing, and its pathogenicity was confirmed by altering the subcellular localization of POU4F3. In addition, we found that two individuals with earlier age of onset and more rapid progression of hearing loss carry additional pathogenic variants in other deafness genes (III-7, STRC:c.4057 C > T; IV-1, GJB2:c.109G > A; CDC14A:c.935G > A). By using the real time quantitative PCR, western blot, luciferase assays and electrophoretic mobility-shift assay, POU4F3 was proved to directly regulate the expression of STRC, GJB2 and CDC14A respectively. ChIP-seq further revealed that POU4F3 can also bind to a series of deafness genes. In summary we expanded the mutation spectrum of POU4F3 by identifying a novel mutation and its pathogenicity. Meanwhile, three genes STRC, GJB2 and CDC14A were validated as POU4F3 new targets, implicating that the variants in the three genes may play a role of genetic modifier to generate a synergistic and enhancement effect on the progression of DFNA15.

摘要

常染色体显性遗传性耳聋15型由POU4F3基因突变引起,已有报道称其临床异质性程度广泛,即使在家族内部成员之间也是如此。然而,其原因仍不清楚。在本研究中,招募了一个四代中国家系,其中11名患者表现为迟发性进行性非综合征性听力损失。该家系中听力损失的表型在发病年龄和进展速度方面表现出很大的变异性。通过全外显子组测序鉴定出一个新的突变(c.706 C>T,p.L236F),并通过改变POU4F3的亚细胞定位证实了其致病性。此外,我们发现两名发病年龄较早且听力损失进展较快的个体在其他耳聋基因中携带额外的致病变异(III-7,STR:c.4057 C>T;IV-1,GJB2:c.109G>A;CDC14A:c.935G>A)。通过实时定量PCR、蛋白质印迹法、荧光素酶测定和电泳迁移率变动分析,证明POU4F3分别直接调节STR、GJB2和CDC14A的表达。染色质免疫沉淀测序进一步揭示POU4F3还可以与一系列耳聋基因结合。总之,我们通过鉴定一个新的突变及其致病性扩展了POU4F3的突变谱。同时,验证了三个基因STR、GJB2和CDC14A为POU4F3的新靶点,这意味着这三个基因中的变异可能起到遗传修饰作用,对DFNA15的进展产生协同和增强效应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/69441326ab98/41598_2025_85881_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/cc3b65f32481/41598_2025_85881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/dbe1ed2857b4/41598_2025_85881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/84386a77770f/41598_2025_85881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/c8154353130b/41598_2025_85881_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/127eda70ae37/41598_2025_85881_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/69441326ab98/41598_2025_85881_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/cc3b65f32481/41598_2025_85881_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/dbe1ed2857b4/41598_2025_85881_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/84386a77770f/41598_2025_85881_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/c8154353130b/41598_2025_85881_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/127eda70ae37/41598_2025_85881_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/524a/11733205/69441326ab98/41598_2025_85881_Fig6_HTML.jpg

相似文献

1
Oligogenic effect is associated with the clinical heterogeneity of autosomal dominant deafness-15.寡基因效应与常染色体显性遗传性耳聋15型的临床异质性相关。
Sci Rep. 2025 Jan 15;15(1):1981. doi: 10.1038/s41598-025-85881-8.
2
Identification of two novel mutations in POU4F3 gene associated with autosomal dominant hearing loss in Chinese families.鉴定与中国常染色体显性遗传性耳聋相关的 POU4F3 基因中的两个新突变。
J Cell Mol Med. 2020 Jun;24(12):6978-6987. doi: 10.1111/jcmm.15359. Epub 2020 May 11.
3
Functional Correlation of Two Novel Nonsense POU4F3 Mutations Causing Late-Onset Progressive Nonsyndromic Hearing Loss in DFNA15 Families.导致DFNA15家族迟发性进行性非综合征性听力损失的两个新型POU4F3无义突变的功能相关性
Mol Genet Genomic Med. 2025 May;13(5):e70100. doi: 10.1002/mgg3.70100.
4
Missense mutations in POU4F3 cause autosomal dominant hearing impairment DFNA15 and affect subcellular localization and DNA binding.POU4F3基因的错义突变导致常染色体显性遗传性听力损失DFNA15,并影响亚细胞定位和DNA结合。
Hum Mutat. 2008 Apr;29(4):545-54. doi: 10.1002/humu.20693.
5
POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss.日本听力损失患者的POU4F3突变筛查:基于大规模平行DNA测序的分析鉴定出与常染色体显性听力损失相关的新变异。
PLoS One. 2017 May 17;12(5):e0177636. doi: 10.1371/journal.pone.0177636. eCollection 2017.
6
Aldh inhibitor restores auditory function in a mouse model of human deafness.醛脱氢酶抑制剂恢复人类耳聋小鼠模型的听觉功能。
PLoS Genet. 2020 Sep 24;16(9):e1009040. doi: 10.1371/journal.pgen.1009040. eCollection 2020 Sep.
7
A novel missense variant in the nuclear localization signal of POU4F3 causes autosomal dominant non-syndromic hearing loss.一个 POU4F3 核定位信号的新型错义变异导致常染色体显性非综合征性听力损失。
Sci Rep. 2017 Aug 8;7(1):7551. doi: 10.1038/s41598-017-08236-y.
8
Exome sequencing identifies POU4F3 as the causative gene for a large Chinese family with non-syndromic hearing loss.外显子组测序确定POU4F3是一个中国非综合征性听力损失大家族的致病基因。
J Hum Genet. 2017 Feb;62(2):317-320. doi: 10.1038/jhg.2016.102. Epub 2016 Aug 18.
9
SNP linkage analysis and whole exome sequencing identify a novel POU4F3 mutation in autosomal dominant late-onset nonsyndromic hearing loss (DFNA15).SNP 连锁分析和全外显子组测序在常染色体显性迟发性非综合征性听力损失(DFNA15)中发现了一个新的 POU4F3 突变。
PLoS One. 2013 Nov 18;8(11):e79063. doi: 10.1371/journal.pone.0079063. eCollection 2013.
10
A Missense Mutation in Causes Midfrequency Hearing Loss in a Chinese ADNSHL Family.一个错义突变导致一个中国 ADNSHL 家系出现中频听力损失。
Biomed Res Int. 2018 Apr 4;2018:5370802. doi: 10.1155/2018/5370802. eCollection 2018.

本文引用的文献

1
Aldh inhibitor restores auditory function in a mouse model of human deafness.醛脱氢酶抑制剂恢复人类耳聋小鼠模型的听觉功能。
PLoS Genet. 2020 Sep 24;16(9):e1009040. doi: 10.1371/journal.pgen.1009040. eCollection 2020 Sep.
2
Identification of two novel mutations in POU4F3 gene associated with autosomal dominant hearing loss in Chinese families.鉴定与中国常染色体显性遗传性耳聋相关的 POU4F3 基因中的两个新突变。
J Cell Mol Med. 2020 Jun;24(12):6978-6987. doi: 10.1111/jcmm.15359. Epub 2020 May 11.
3
Digenic inheritance of mutations in EPHA2 and SLC26A4 in Pendred syndrome.
常染色体隐性遗传的 EPHA2 和 SLC26A4 基因突变导致 Pendred 综合征。
Nat Commun. 2020 Mar 12;11(1):1343. doi: 10.1038/s41467-020-15198-9.
4
Pou4f3 gene mutation promotes autophagy and apoptosis of cochlear hair cells in cisplatin-induced deafness mice.Pou4f3 基因突变促进顺铂致聋小鼠耳蜗毛细胞的自噬和凋亡。
Arch Biochem Biophys. 2020 Feb 15;680:108224. doi: 10.1016/j.abb.2019.108224. Epub 2019 Dec 9.
5
Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders.超越单基因-单疾病模式:遗传性心脏疾病中的复杂遗传学和多效性。
Circulation. 2019 Aug 13;140(7):595-610. doi: 10.1161/CIRCULATIONAHA.118.035954. Epub 2019 Aug 12.
6
Consensus interpretation of the p.Met34Thr and p.Val37Ile variants in GJB2 by the ClinGen Hearing Loss Expert Panel.ClinGen 听力损失专家小组对 GJB2 中 p.Met34Thr 和 p.Val37Ile 变异的共识解读。
Genet Med. 2019 Nov;21(11):2442-2452. doi: 10.1038/s41436-019-0535-9. Epub 2019 Jun 4.
7
Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing loss.遗传听力损失 ACMG/AMP 变异解读指南的专家规范
Hum Mutat. 2018 Nov;39(11):1593-1613. doi: 10.1002/humu.23630.
8
Oligogenic familial hypercholesterolemia, LDL cholesterol, and coronary artery disease.寡基因家族性高胆固醇血症、低密度脂蛋白胆固醇与冠状动脉疾病。
J Clin Lipidol. 2018 Nov-Dec;12(6):1436-1444. doi: 10.1016/j.jacl.2018.08.006. Epub 2018 Aug 23.
9
Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion.解读 ACMG/AMP 失能性预测标准的 PVS1 变异准则的建议。
Hum Mutat. 2018 Nov;39(11):1517-1524. doi: 10.1002/humu.23626. Epub 2018 Sep 7.
10
DFNB1 Non-syndromic Hearing Impairment: Diversity of Mutations and Associated Phenotypes.DFNB1 型非综合征性听力损失:突变的多样性及相关表型
Front Mol Neurosci. 2017 Dec 22;10:428. doi: 10.3389/fnmol.2017.00428. eCollection 2017.